SARS-CoV patients had reactivatable CD4+ and CD8+ T cells 6 years after infection [102], and this reactivity was specific as SARS-CoV reactivity could be transferred to other T cells through recombinant expression of the cloned TCR [103]. This evidence concerns the gene CD8A and infection.